21780103|androgen receptor|C1367578|start=61|end=78|GENE
21780103|prostate tumor|C0033578|start=90|end=104|DISO
21780103|progression|C0242656^C0449258|start=105|end=116|DISO^CONC
21780103|androgen receptor|C1367578|start=122|end=139|GENE
21780103|plays|C0032214|start=145|end=150|ACTI
21780103|central|C0205099|start=153|end=160|CONC
21780103|role|C1705809^C0035820^C1705812^C1704326^C1705811^C1705810|start=161|end=165|ACTI^CONC
21780103|prostate cancer|C0376358^C0600139^C2984325^C3541264|start=169|end=184|DISO^CONC
21780103|progression|C0242656^C0449258|start=185|end=196|DISO^CONC
21780103|castration|C0029189^C0007344|start=204|end=214|PROC
21780103|resistant|C0332325^C2827757|start=215|end=224|PHEN^CONC
21780103|state|C1552743^C1301808^C3148680^C1442792|start=237|end=242|GEOG^ORGA^CONC
21780103|ddc|C1413943|start=266|end=269|GENE
21780103|increases|C0442805^C0205217|start=297|end=306|CONC
21780103|expression|C0185117^C0017262^C2911684|start=310|end=320|PROC^PHYS^CONC
21780103|disease progression|C0242656|start=326|end=345|DISO
21780103|prostate adenocarcinoma|C0007112|start=386|end=409|DISO
21780103|cells|C3282337^C0007634|start=410|end=415|ANAT
21780103|may|C3812381|start=426|end=429|CONC
21780103|enhance|C2349975|start=430|end=437|ACTI
21780103|activity|C0026606^C0441655^C0205177|start=441|end=449|ACTI^CONC
21780103|ddc|C1413943|start=481|end=484|GENE
21780103|inhibitor|C1999216|start=495|end=504|CONC
21780103|suppress|C1260953|start=521|end=529|CONC
21780103|ddc|C1413943|start=530|end=533|GENE
21780103|retard|C0521111|start=557|end=563|CONC
21780103|prostate tumor|C0033578|start=564|end=578|DISO
21780103|growth|C2911660^C0220844^C0018270^C1621966|start=579|end=585|PHYS^ACTI
21780103|treating|C1522326|start=587|end=595|CONC
21780103|prostate cancer|C0376358^C0600139^C2984325^C3541264|start=602|end=617|DISO^CONC
21780103|cells|C3282337^C0007634|start=618|end=623|ANAT
21780103|transcriptional|C0040649|start=642|end=657|PHYS
21780103|suppressed|C1260953|start=665|end=675|CONC
21780103|enhanced|C2349975|start=680|end=688|ACTI
21780103|transactivation|C0040624|start=692|end=707|PHYS
21780103|seen|C0205397|start=708|end=712|CONC
21780103|ddc|C1413943|start=718|end=721|GENE
21780103|overexpression|C1514559|start=722|end=736|PHYS
21780103|decreased|C0392756^C0205216^C0442797|start=741|end=750|CONC
21780103|prostate-specific antigen|C1366489|start=751|end=776|GENE
21780103|psa|C0687688^C1426033^C1417779^C2347427^C3810537^C3813209^C0201544^C1418948^C1366489^C1705954^C1519176^C3272395|start=778|end=781|DISO^PROC^GENE^CONC
21780103|levels|C0441889|start=788|end=794|CONC
21780103|dose|C0869039^C0178602|start=806|end=810|CONC
21780103|inhibited|C0311403|start=823|end=832|CONC
21780103|cell growth|C0007595|start=833|end=844|PHYS
21780103|decreased|C0392756^C0205216^C0442797|start=849|end=858|CONC
21780103|survival|C0038952^C0220921|start=859|end=867|ACTI^CONC
21780103|cell proliferation|C0596290|start=877|end=895|PHYS
21780103|apoptosis|C0162638|start=900|end=909|PHYS
21780103|inhibitory|C3463820|start=922|end=932|ACTI
21780103|effect|C2348382^C1280500|start=933|end=939|CONC
21780103|ddc|C1413943|start=956|end=959|GENE
21780103|cell growth|C0007595|start=983|end=994|PHYS
21780103|survival|C0038952^C0220921|start=995|end=1003|ACTI^CONC
21780103|observed|C1441672|start=1013|end=1021|CONC
21780103|pc3|C3714948^C1423866^C1704969^C0450691^C1366526^C1418388|start=1025|end=1028|DISO^GENE^ANAT
21780103|prostate cancer|C0376358^C0600139^C2984325^C3541264|start=1029|end=1044|DISO^CONC
21780103|cells|C3282337^C0007634|start=1045|end=1050|ANAT
21780103|in vivo|C1515655|start=1075|end=1082|CONC
21780103|studies|C0947630|start=1083|end=1090|PROC
21780103|serum|C0229671^C1546774^C1550100|start=1109|end=1114|ANAT^CONC
21780103|psa velocity|C1518823|start=1115|end=1127|PROC
21780103|tumor growth|C0598934|start=1132|end=1144|DISO
21780103|elevated|C3163633^C0205250|start=1151|end=1159|CONC
21780103|approximately|C0332232|start=1160|end=1173|CONC
21780103|fold|C0332462^C1880834|start=1176|end=1180|PHEN^CONC
21780103|xenografts|C0520484|start=1190|end=1200|PROC
21780103|ddc|C1413943|start=1227|end=1230|GENE
21780103|control|C1547100^C0243148^C3274648^C2587213^C1882979^C1550141|start=1249|end=1256|OBJC^CONC
21780103|levels|C0441889|start=1257|end=1263|CONC
21780103|administration|C1533734^C0001554|start=1279|end=1293|PROC^ACTI
21780103|mice|C1413131^C1417166|start=1308|end=1312|GENE
21780103|treating|C1522326|start=1314|end=1322|CONC
21780103|tumors|C0027651|start=1329|end=1335|DISO
21780103|endogenous|C0205227|start=1348|end=1358|CONC
21780103|ddc|C1413943|start=1359|end=1362|GENE
21780103|delayed|C0205421^C3272602|start=1379|end=1386|CONC
21780103|progression|C0242656^C0449258|start=1387|end=1398|DISO^CONC
21780103|state|C1552743^C1301808^C3148680^C1442792|start=1409|end=1414|GEOG^ORGA^CONC
21780103|weeks|C0439230|start=1428|end=1433|CONC
21780103|serum|C0229671^C1546774^C1550100|start=1441|end=1446|ANAT^CONC
21780103|psa|C0687688^C1426033^C1417779^C2347427^C3810537^C3813209^C0201544^C1418948^C1366489^C1705954^C1519176^C3272395|start=1447|end=1450|DISO^PROC^GENE^CONC
21780103|tumor growth|C0598934|start=1455|end=1467|DISO
21780103|decreased|C0392756^C0205216^C0442797|start=1468|end=1477|CONC
21780103|fold|C0332462^C1880834|start=1482|end=1486|PHEN^CONC
21780103|fold|C0332462^C1880834|start=1495|end=1499|PHEN^CONC
21780103|study|C0947630^C2603343^C0557651^C0008972^C1705923^C1880229|start=1519|end=1524|PROC^OBJC^CONC
21780103|is a|C1292718|start=1525|end=1529|CONC
21780103|time|C0040223^C1548318^C1547403^C3541383|start=1536|end=1540|CONC
21780103|ddc|C1413943|start=1583|end=1586|GENE
21780103|prostate cancer|C0376358^C0600139^C2984325^C3541264|start=1609|end=1624|DISO^CONC
21780103|cells|C3282337^C0007634|start=1625|end=1630|ANAT
21780103|tumors|C0027651|start=1635|end=1641|DISO
21780103|decrease|C0392756^C0547047|start=1643|end=1651|CONC
21780103|serum|C0229671^C1546774^C1550100|start=1652|end=1657|ANAT^CONC
21780103|psa|C0687688^C1426033^C1417779^C2347427^C3810537^C3813209^C0201544^C1418948^C1366489^C1705954^C1519176^C3272395|start=1658|end=1661|DISO^PROC^GENE^CONC
21780103|tumor growth|C0598934|start=1670|end=1682|DISO
21780103|delay|C0205421|start=1687|end=1692|CONC
21780103|progression|C0242656^C0449258|start=1696|end=1707|DISO^CONC
21780103|approved|C1549489^C2346846^C0205540|start=1739|end=1747|CONC
21780103|may|C3812381|start=1752|end=1755|CONC
21780103|novel|C0205314^C0679622|start=1777|end=1782|CONC
21780103|therapeutic|C0039796^C1547427^C0302350|start=1783|end=1794|PROC^CONC
21780103|strategy|C0679199|start=1795|end=1803|PHYS
21780103|suppress|C1260953|start=1807|end=1815|CONC
21780103|aberrant|C0443127|start=1816|end=1824|CONC
21780103|activity|C0026606^C0441655^C0205177|start=1828|end=1836|ACTI^CONC
21780103|delay|C0205421|start=1841|end=1846|CONC
21780103|prostate cancer|C0376358^C0600139^C2984325^C3541264|start=1847|end=1862|DISO^CONC
21780103|progression|C0242656^C0449258|start=1863|end=1874|DISO^CONC
